©The Author(s) 2015.
World J Gastroenterol. Dec 14, 2015; 21(46): 13166-13176
Published online Dec 14, 2015. doi: 10.3748/wjg.v21.i46.13166
Published online Dec 14, 2015. doi: 10.3748/wjg.v21.i46.13166
Table 4 Neutropenic precautions and infectious adverse events
| Study | Neutropenic precautions | Infectious adverse events |
| n = No. of afebrile neutropenic patients | ||
| Buderus et al[19] | ANC < 1000/mm3 threshold: | One (2.1%) procedure-related adverse event: |
| Upper endoscopies performed under “aseptic conditions” (not defined), appears that this did not include antibiotic prophylaxis | Fever and abdominal tenderness after colonoscopy | |
| Colonoscopies performed under antibiotic prophylaxis n = 10 (ANC < 1000/mm3) | Patient had not received antibiotic prophylaxis despite neutropenia (ANC 490/mm3); no explanation given in article | |
| Symptoms resolved in 2 d under IV antibiotics | ||
| Chu et al[17] | None | None |
| n = unknown | ||
| Gorschlüter et al[20] | Neutropenia not defined | 16 of 106 (15%) primary upper EGD: Fever within 48 h |
| n = unknown | 3 of 20 (15%) primary colonoscopies: Fever within 48 h | |
| Median WBC 1.5 G/l | Total # patients with fever following endoscopy: 19. | |
| 5 of these died within 10 d. | ||
| Not significantly different from # patients who died without having a fever following endoscopy. | ||
| No ERCP-related adverse events | ||
| Kaur et al[22] | Neutropenia not defined | 2 deaths due to sepsis |
| n = unknown | No adverse events attributed to endoscopy | |
| Kaur et al[23] | No neutropenic precautions taken | 4 (36%) infectious adverse events total (both neutropenic and non-neutropenic) |
| n = 4 (ANC < 1500/mm3) | ||
| 2 patients neutropenic at time of PEG placement. | ||
| First patient had cellulitis and small abscess at PEG site, treated by removal of PEG | ||
| Second patient had cellulitis at PEG site, treated by IV antibiotics | ||
| 2 patients non-neutropenic at time of PEG placement, but had neutropenia at the time of infection | ||
| Khan et al[24] | For ANC < 1000/mm3: | No infectious adverse events related to endoscopy. |
| Broad-spectrum antibiotics prophylaxis | 1 colonic perforation resulting in death | |
| n = 148 (WBC < 4000/mm3) | ||
| Park et al[21] | “Severe aplastic anemia” defined as bone marrow cellularity less than 25% and very low values for at least 2 of 3 hematopoietic lineages (including ANC < 500/mm3) | No adverse events attributable to endoscopy |
| No precautions (no patients with fever) | ||
| n = 28 (Severe aplastic anemia) | ||
| Ross et al[25] | None | None reported |
| n = 0 | ||
| Schulenburg et al[26] | Antibiotic prophylaxis during aplasia for all patients | None |
| No extra prophylaxis for endoscopy | ||
| Schwartz et al[18] | None | No adverse events attributable to endoscopy |
| n = unknown | ||
| Soylu et al[27] | Severe neutropenia (level not defined): | No adverse events attributable to endoscopy |
| Withhold endoscopy in 17 upper and 7 lower GI bleed episodes | ||
| n = unknown |
- Citation: Tong MC, Tadros M, Vaziri H. Endoscopy in neutropenic and/or thrombocytopenic patients. World J Gastroenterol 2015; 21(46): 13166-13176
- URL: https://www.wjgnet.com/1007-9327/full/v21/i46/13166.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i46.13166